Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,322,880
  • Shares Outstanding, K 1,767,398
  • Annual Sales, $ 30,578 M
  • Annual Income, $ 2,368 M
  • 60-Month Beta 1.13
  • Price/Sales 4.76
  • Price/Cash Flow 17.14
  • Price/Book 4.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.95
  • Number of Estimates 9
  • High Estimate 0.96
  • Low Estimate 0.94
  • Prior Year 0.81
  • Growth Rate Est. (year over year) +17.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.51 +5.45%
on 10/08/19
84.77 -2.34%
on 10/01/19
-0.85 (-1.02%)
since 09/18/19
3-Month
78.51 +5.45%
on 10/08/19
88.76 -6.73%
on 07/23/19
-4.97 (-5.66%)
since 07/18/19
52-Week
65.44 +26.51%
on 12/24/18
88.76 -6.73%
on 07/23/19
+14.65 (+21.50%)
since 10/18/18

Most Recent Stories

More News
TLC Appoints Vincent Chang, PhD, as Vice President of Manufacturing Development

TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medical need...

ABT : 82.79 (+0.50%)
3 Medical Product Stocks Likely to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

JNJ : 127.70 (-6.22%)
ABT : 82.79 (+0.50%)
VAR : 114.62 (+0.44%)
RMD : 131.21 (-0.32%)
MDT : 108.12 (-0.36%)
CGC : 20.21 (-2.65%)
QTRX : 20.95 (-3.81%)
Asian shares mixed on caution over China-US trade deal

BANGKOK (AP) — Asian shares were mixed Thursday after officials signaled work remains to be done on an agreement for a truce in the tariff war between the U.S. and China.

BAC : 30.35 (+0.30%)
JPM : 120.56 (+0.17%)
ABT : 82.79 (+0.50%)
IBM : 134.09 (-0.13%)
CAH : 51.54 (+0.64%)
ADBE : 265.52 (-1.38%)
MCK : 152.26 (+1.16%)
GM : 36.17 (-0.06%)
MSFT : 137.41 (-1.63%)
UAL : 90.08 (+0.70%)
Markets Right Now: Stocks close mostly lower on Wall Street

NEW YORK (AP) — The latest on developments in financial markets (all times local):

ABT : 82.79 (+0.50%)
GM : 36.17 (-0.06%)
CAH : 51.54 (+0.64%)
MCK : 152.26 (+1.16%)
Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance

We are optimistic about Abbott's (ABT) strong and consistent EPD and Medical Devices performance organically.

ABT : 82.79 (+0.50%)
VAR : 114.62 (+0.44%)
MDT : 108.12 (-0.36%)
SYNH : 55.03 (-0.61%)
Abbott (ABT) Meets Q3 Earnings Estimates

Abbott (ABT) delivered earnings and revenue surprises of 0.00% and -0.23%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ABT : 82.79 (+0.50%)
Abbott: 3Q Earnings Snapshot

ABBOTT PARK, Ill. (AP) _ Abbott Laboratories (ABT) on Wednesday reported third-quarter net income of $960 million.

ABT : 82.79 (+0.50%)
Abbott Reports Third-Quarter 2019 Results

Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2019.

ABT : 82.79 (+0.50%)
Abbott Laboratories to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 16, 2019 / Abbott Laboratories (NYSE: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 16, 2019 at 9:00 AM Eastern...

ABT : 82.79 (+0.50%)
Tandem Diabetes is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (TNDM, PODD , ABT , ZBH , HOLX )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

ABT : 82.79 (+0.50%)
PODD : 153.74 (-1.75%)
TNDM : 63.58 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ABT with:

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 84.01
1st Resistance Point 83.40
Last Price 82.79
1st Support Level 82.10
2nd Support Level 81.42

See More

52-Week High 88.76
Last Price 82.79
Fibonacci 61.8% 79.85
Fibonacci 50% 77.10
Fibonacci 38.2% 74.35
52-Week Low 65.44

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar